With Funding Secured, Malaria Vaccine Pilots Set To Begin In Africa In 2018, WHO Says

Reuters: WHO says funds secured for Africa pilots of world’s first malaria vaccine
“Funding for phase one of pilot deployments of the world’s first malaria vaccine in sub-Saharan Africa has been secured and immunization campaigns will begin in 2018, the World Health Organization (WHO) said on Thursday…” (Kelland, 11/17).

U.N. News Centre: World’s first malaria vaccine set for 2018 rollout in Africa after U.N. health agency secures funding
“…The vaccine, known as RTS,S, acts globally against the most deadly malaria parasite P. falciparum, very common in Africa. Based on the results from clinical trials, the new vaccine will provide partial protection against malaria in young children. The vaccine was developed through a partnership between GlaxoSmithKline and the PATH Malaria Vaccine Initiative (MVI), with support from the Bill & Melinda Gates Foundation and from a network of African research centers…” (11/17).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.